A comprehensive review of the cannabis delivery business model, market impact, investment risks, and new Virginia marijuana rules for DMV entrepreneurs and investors.

Explore how Nature’s Treatment of Illinois shapes dispensary experiences in Milan and Galesburg, with takeaways for savvy shoppers and DMV delivery innovators.

Explore the comprehensive guide to D2 Dispensary Downtown (Medical), a cornerstone for medical marijuana in Tucson focusing on patient support, product variety, and local impact.

Employee ownership plans aren't just perks—they're game-changers for DC, Maryland, and Virginia’s cannabis delivery industry, boosting retention and long-term value.

Dive deep into Green Thumb Industries' RISE Dispensaries, product lines, MSO operations, and their significance for DMV cannabis consumers.

NCV’s data shows flat-to-declining revenue momentum for many public operators while the market fixates on 280E and rescheduling risk—here’s what that means for DMV investors and delivery entrepreneurs.

NCIA experts outline five early-stage decisions that make or break cannabis facilities. Here’s how DMV founders, delivery operators, and investors can apply them.

California brand Greenline opens its first store, completing a seed-to-sale model. Here’s what a vertical move like this means for delivery, investors, and DMV entrepreneurs.

Spherex’s first-ever acquisition brings Denver indoor and Trinidad outdoor cultivation in-house amid Colorado supply volatility—here’s what it signals for ops and investors.

An Australian firm filed a THC-free CBD pain tablet with TGA approval in mind, but its own trial reportedly didn’t beat placebo—raising product, market, and investor questions.

Design is now a core revenue lever in cannabis. Here’s how modern dispensaries win on branding, flow and merchandising—plus what DMV operators should plan for.

Kentucky’s slow medical rollout spotlights how supply gaps and licensing timelines ripple through delivery economics. Here’s what operators and investors should do next.

Durango Organics’ Jonny Radding shares survival themes from Colorado’s boom-bust. We translate them into delivery models, DMV opportunities, and investor risk checks.

A new DEA registration pathway pulls state-licensed medical cannabis manufacturers, distributors, and labs into the federal Schedule III framework—potentially easing 280E tax pain.

Canopy Growth will supply four Canadian-grown flower strains to UK patients through GROW Group—an expansion with ripple effects for delivery, logistics, and investors across the European cannabis market.

Missouri is set to issue about 77 marijuana microbusiness licenses after a September drawings round. Here’s how new owners can avoid predatory contracts—and what DMV founders and investors can learn.

Dispensary events are surging in 2026. Here’s how timing, team standards, and promo strategy turn pop-ups and anniversaries into real revenue—and what DMV operators should do now.

High Times reports Italy’s fentanyl scarcity despite entrenched opioid use and powerful crime networks. We unpack what that evidence means for drug markets—and the cannabis delivery business.

New York just doubled its licensed dispensaries to 556, with 200+ in NYC. Here’s what that expansion signals for delivery models, investors, and DMV entrepreneurs.

Alleged retaliatory firings at a Missouri dispensary highlight workforce risks that can ripple into dispensary delivery, cannabis delivery apps, and investor sentiment across markets.